We can hypothesize that ischemia and the intense inflammatory response observed within the first hours after AMI may lead to an upregulation of P2Y11 in circulating immune cells thus modulating the systemic and local immune response and preventing the deleterious effects of an excessive inflammation. The gene discussed is P2RY11; the disease is ischemia.